Annual Drug Patent Expirations for CRESTOR
Crestor is a drug marketed by IPR and is included in one NDA. It is available from four suppliers. There is one patent protecting this drug and one Paragraph IV challenge.
Drug patent litigation for CRESTOR.
The generic ingredient in CRESTOR is rosuvastatin calcium. Four suppliers are listed for this compound. Additional details are available on the rosuvastatin calcium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
